Retinal diseases are a major cause of severe vision loss, with numbers constantly increasing due to the aging of the population, the diabetes epidemic and the growing prevalence of high myopia.
At the same time, science is progressing, with higher efficacy and durability of pharmacotherapies, breakthrough therapies recently approved and novel approaches in the pipeline. To meet the challenges of this exponential increase in the number of patients needing diagnosis, monitoring and treatment, a transformative approach is required.
“The community has understood that artificial intelligence